Migraine relief recall: Medicine sold nationwide through Amazon has 'significant risk of misuse' due to lack of labels
Briefly

The recall was initiated due to the batch's lack of manufacturer labels, posing a significant risk of misuse and potential health hazards like liver damage and allergic reactions.
As of the announcement date, no injuries were reported related to the recall, even though the product had been shipped nationwide by Amazon in January with missing labels.
Read at Fast Company
[
|
]